Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2005

View Archived Issues

Nautilus achieves milestone in Serono hGH collaboration

PTC Therapeutics receives award to support development of PTC-124

Codevelopment agreement for tramadol hydrochloride in Japan

New phase I/II study of AP-12009

Drug discovery milestone in Astex's collaboration with Boehringer Ingelheim

Completion of treatment in Cubicin endocarditis/bacteremia study

Aerogen receives fast track status for aerosolized amikacin

GenVec expands testing of AdPEDF for AMD

Enrollment begins in phase III study of ICA-17043 for sickle cell disease

Enrollment completed in ATLAS study of Taxus Liberte stent

FDA approves amendments to ARISE study of AGI-1067

PhytoMedical enters agreement for animal studies of BDC-03

Update on the antitumor effects of autologous Xcellerated T-cells in hematological malignancies

Clinical evidence supports the use of oral fumarate BG-12 in psoriasis

Rofecoxib increases blood pressure in hypertensive patients with type 2 diabetes

Enablex launched in U.S.

Atacand approved for treatment of heart failure

Positive opinion in Europe for Invirase 500 mg

CVT-5440: a selective, high affinity adenosine A2B receptor antagonist for asthma therapy

Entecavir reported effective against recurrent HBV viremia in HIV/HBV coinfection

Novel 5-HT/noradrenaline reuptake inhibitors claimed by Pfizer

Roche presents tetraazaphenalene derivatives with anticancer activity

Two novel series of PDE7 inhibitors imparted by Daiichi Suntory

Lysophospholipid receptor ligands disclosed by Novartis

Scientists at Schering AG describe new VEGFR-2 inhibitors and their use

Novel tachykinin antagonists developed by Fujisawa

New steroid compounds for use in X-ray contrast media claimed by Fuji Photo Film

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...